BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8167688)

  • 1. Characterization of anergy to the superantigen Staphylococcus enterotoxin B.
    Dannecker G; Schultz H; Mecheri S; Sappler G; Clarke K; Niethammer D; Hoffmann MK
    Immunodeficiency; 1993; 4(1-4):137-9. PubMed ID: 8167688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR; MacDonald HR
    Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal anergy to staphylococcal enterotoxin B in vivo: selective effects on T cell subsets and lymphokines.
    Baschieri S; Lees RK; Lussow AR; MacDonald HR
    Eur J Immunol; 1993 Oct; 23(10):2661-6. PubMed ID: 8104798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
    J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superantigen-induced anergy in cytotoxic CD8+ T cells.
    Sundstedt A; Höidén I; Hansson J; Hedlund G; Kalland T; Dohlsten M
    J Immunol; 1995 Jun; 154(12):6306-13. PubMed ID: 7759869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The superantigen Staphylococcus enterotoxin B induces a strong and accelerated secondary T-cell response rather than anergy.
    Schultz H; Geiselhart A; Sappler G; Niethammer D; Hoffmann MK; Dannecker GE
    Immunology; 1996 Jan; 87(1):49-54. PubMed ID: 8666435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppression: dose-response relationship.
    Miethke T; Wahl C; Gaus H; Heeg K; Wagner H
    Eur J Immunol; 1994 Aug; 24(8):1893-902. PubMed ID: 8056049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
    Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
    J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis toxin interferes with superantigen-induced deletion of peripheral T cells without affecting T cell activation in vivo. Inhibition of deletion and associated programmed cell death depends on ADP-ribosyltransferase activity.
    Gonzalo JA; González-García A; Baixeras E; Zamzami N; Tarazona R; Rappuoli R; Martínez C; Kroemer G; Tarazona R; Terezone R
    J Immunol; 1994 May; 152(9):4291-9. PubMed ID: 7908917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice.
    Scott DE; Kisch WJ; Steinberg AD
    J Immunol; 1993 Jan; 150(2):664-72. PubMed ID: 8419493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
    Lane P; Haller C; McConnell F
    Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue.
    Spiekermann GM; Nagler-Anderson C
    J Immunol; 1998 Dec; 161(11):5825-31. PubMed ID: 9834060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigen-mediated deletion of specific T cell receptor V beta subsets in the SCID-hu Thy/Liv mouse is induced by staphylococcal enterotoxin B, but not HIV-1.
    Komanduri KV; Salha MD; Sékaly RP; McCune JM
    J Immunol; 1997 Jan; 158(2):544-9. PubMed ID: 8992966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD1+ human thymocytes proliferate in response to superantigen staphylococcal enterotoxin B1.
    Todd SC; Baccala R; Hedrick JA; Theofilopoulos AN; Tsoukas CD
    J Immunol; 1994 Sep; 153(5):2038-45. PubMed ID: 7519639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway.
    Gonzalo JA; Moreno de Alborán I; Alés-Martínez JE; Martínez C; Kroemer G
    Eur J Immunol; 1992 Apr; 22(4):1007-11. PubMed ID: 1551401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigen-induced anergy of V beta 8+ CD4+ T cells induces functional but non-proliferative T cells in vivo.
    Gaus H; Miethke T; Wagner H; Heeg K
    Immunology; 1994 Nov; 83(3):333-40. PubMed ID: 7835956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells.
    Shimizu M; Yamamoto A; Nakano H; Matsuzawa A
    Cancer Res; 1996 Aug; 56(16):3731-6. PubMed ID: 8706016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of activation markers during tolerance induction by superantigens in T-cell receptor (beta-chain) transgenic mice.
    Perkins DL; Listman JA; Wang Y; Ho SS; Finn PW; Rimm IJ
    Cell Immunol; 1994 Jul; 156(2):310-21. PubMed ID: 8025950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of clonal anergy by oral administration of staphylococcal enterotoxin B.
    Migita K; Ochi A
    Eur J Immunol; 1994 Sep; 24(9):2081-6. PubMed ID: 8088329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T; Wahl C; Heeg K; Wagner H
    J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.